Health Care · Pharmaceutical Preparations · Nasdaq · CIK 2025942 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $0.20Day +8.20%Mkt cap $6MOff 52W high −97.8%Vol (1Y) 141.4%
Daily closing price, split-adjusted to the current basis; 0.9y shown of 221 bars on file. Sampled to 221 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.0% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)−0.02% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-09-29 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$7.2M |
| ROE−72.1% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−40.1% |
Total return through 2026-07-28 · series begins 2025-08-26. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)141.4% |
| Ann. volatility (3Y)141.4% |
| Sharpe (1Y)−1.25 |
| Sharpe (3Y)−1.25 |
| Max drawdown (1Y)−98.0% |
| Max drawdown (3Y)−98.0% |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 111,130 | $56,820 | 0.39% | +495.2% |
| TWO SIGMA SECURITIES, LLC | 56,651 | $28,966 | 0.20% | new |
| XTX Topco Ltd | 51,289 | $26,224 | 0.18% | +21.0% |
| CITADEL ADVISORS LLC | 50,559 | $25,851 | 0.18% | −51.5% |
| TWO SIGMA INVESTMENTS, LP | 20,254 | $10,356 | 0.07% | −66.9% |
| CITIGROUP INC | 19,332 | $9,884 | 0.07% | new |
| Jump Financial, LLC | 10,551 | $5,392 | 0.04% | −39.5% |
| UBS Group AG | 7,995 | $4,085 | 0.03% | −38.5% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$0.11 | — | — | — |
| 2025-09-30 | 2025-11-17 | −$0.04 | — | — | — |
| 2025-06-30 | 2025-09-09 | $0.00 | — | — | — |
| 2025-03-31 | — | −$0.01 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-09-29 is ESTIMATED from filing cadence (median gap 69d) — not company-confirmed.
